Grazoprevir
- Generic Name
- Grazoprevir
- Brand Names
- Zepatier
- Drug Type
- Small Molecule
- Chemical Formula
- C38H50N6O9S
- CAS Number
- 1350514-68-9
- Unique Ingredient Identifier
- 8YE81R1X1J
- Background
Grazoprevir is a direct acting antiviral medication used as part of combination therapy to treat chronic Hepatitis C, an infectious liver disease caused by infection with Hepatitis C Virus (HCV). HCV is a single-stranded RNA virus that is categorized into nine distinct genotypes, with genotype 1 being the most common in the United States, and affecting 72% o...
- Indication
Grazoprevir is indicated in combination with Elbasvir (as the fixed dose combination product Zepatier) with or without Ribavirin for treatment of chronic HCV genotypes 1a, 1b, or 4 infection in adults.
- Associated Conditions
- Chronic Hepatitis C Genotype 1, Chronic hepatitis C genotype 1a, Genotype 4 Chronic Hepatitis C
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath